Skip to main page content

Review

. 2020 Mar;70(2):78-85.

doi: 10.3322/caac.21599. Epub 2020 Feb 26.

Metastatic melanoma

Ragini R Kudchadkar¹, Michael C Lowe², Mohammad K Khan³, Stephanie M McBrien¹

Affiliations

Affiliations

¹ Department of Hematology/Oncology, Emory Winship Cancer Institute, Atlanta, Georgia.
² Department of Surgery, Emory Winship Cancer Institute, Atlanta, Georgia.
³ Department of Radiation Oncology, Emory Winship Cancer Institute, Atlanta, Georgia.

PMID: 32101327
DOI: 10.3322/caac.21599

Free article

Review

Metastatic melanoma

Ragini R Kudchadkar et al. CA Cancer J Clin. 2020 Mar.

Free article

. 2020 Mar;70(2):78-85.

doi: 10.3322/caac.21599. Epub 2020 Feb 26.

Authors

Ragini R Kudchadkar¹, Michael C Lowe², Mohammad K Khan³, Stephanie M McBrien¹

Affiliations

¹ Department of Hematology/Oncology, Emory Winship Cancer Institute, Atlanta, Georgia.
² Department of Surgery, Emory Winship Cancer Institute, Atlanta, Georgia.
³ Department of Radiation Oncology, Emory Winship Cancer Institute, Atlanta, Georgia.

PMID: 32101327
DOI: 10.3322/caac.21599

No abstract available

PubMed Disclaimer

Similar articles

Undifferentiated Sarcoma as Intermediate Step in Rhabdomyosarcomatous Transformation of a Metastatic Malignant Melanoma Resistant to Anti-BRAF Therapy: A Phenomenon Associated With Significant Diagnostic and Therapeutic Pitfalls.
Tran TAN. Tran TAN. Int J Surg Pathol. 2019 Sep;27(6):669-677. doi: 10.1177/1066896919839143. Epub 2019 Apr 3. Int J Surg Pathol. 2019. PMID: 30942107
Ground-glass opacity of the lung in a patient with melanoma: "The radiological seed of doubt".
Dalpiaz G, Kawamukai K, Parisi AM, La Torre L, Forcella D, Leuzzi G. Dalpiaz G, et al. Rev Esp Med Nucl Imagen Mol. 2015 Nov-Dec;34(6):390-2. doi: 10.1016/j.remn.2015.04.006. Epub 2015 Jun 3. Rev Esp Med Nucl Imagen Mol. 2015. PMID: 26049663 English, Spanish. No abstract available.
Prolonged untreated and treated course of a malignant melanoma.
Nashan D, Haufs MG, Kleinheinz J, Al-Dandashi C, Bruckner-Tuderman L. Nashan D, et al. Dermatology. 2006;212(1):93-5. doi: 10.1159/000089034. Dermatology. 2006. PMID: 16319486 No abstract available.
[Latest treatment strategy for pulmonary metastases in breast cancer].
Yoshizawa K. Yoshizawa K. Nihon Rinsho. 2002 May;60 Suppl 5:521-5. Nihon Rinsho. 2002. PMID: 12101726 Review. Japanese. No abstract available.
[The gastrointestinal tract as the metastatic site of malignant epithelial tumors].
Madeya S, Börsch G. Madeya S, et al. Ergeb Inn Med Kinderheilkd. 1992;60:65-101. Ergeb Inn Med Kinderheilkd. 1992. PMID: 1582404 Review. German. No abstract available.

See all similar articles

Cited by

Has-miR-300-GADD45B promotes melanoma growth via cell cycle.
Chen L, Fang C, Yuan X, Liu M, Wu P, Zhong L, Chen Z. Chen L, et al. Aging (Albany NY). 2023 Dec 7;15(23):13920-13943. doi: 10.18632/aging.205276. Epub 2023 Dec 7. Aging (Albany NY). 2023. PMID: 38070141 Free PMC article.
Morphological aspects and therapeutic options in melanoma: a narrative review of the past decade.
Tinca AC, Raicea A, Szőke AR, Cocuz IG, Şincu MC, Niculescu R, Sabău AH, Popelea MC, Fruntelată RF, Cotoi OS. Tinca AC, et al. Rom J Morphol Embryol. 2023 Apr-Jun;64(2):135-141. doi: 10.47162/RJME.64.2.02. Rom J Morphol Embryol. 2023. PMID: 37518869 Free PMC article. Review.
Comprehensive Analysis to Identify LINC00511-hsa-miR-625-5p-SEMA6A Pathway Fuels Progression of Skin Cutaneous Melanoma.
Chen G, Yan J, Fu Z. Chen G, et al. Int J Genomics. 2023 Jul 3;2023:6422941. doi: 10.1155/2023/6422941. eCollection 2023. Int J Genomics. 2023. PMID: 37434634 Free PMC article.
Intrathymic Localization of Melanoma: A Brief Report of Two Cases and a Review of the Literature.
Cannone G, Verzeletti V, Fortarezza F, Pezzuto F, Polverosi R, Faccioli E, Comacchio GM, Dell'Amore A, Rea F, Schiavon M, Calabrese F. Cannone G, et al. Diagnostics (Basel). 2023 Jun 9;13(12):2017. doi: 10.3390/diagnostics13122017. Diagnostics (Basel). 2023. PMID: 37370911 Free PMC article.
Inhibition of TAZ impairs the migration ability of melanoma cells.
Zhang H, Tu L, Ma Z, Lin Y, Tan Q. Zhang H, et al. Open Life Sci. 2023 Jun 21;18(1):20220633. doi: 10.1515/biol-2022-0633. eCollection 2023. Open Life Sci. 2023. PMID: 37360787 Free PMC article.

See all "Cited by" articles

References

1. Sade-Feldman M, Yizhak K, Bjorgaard SL, et al. Defining T cell states associated with response to checkpoint immunotherapy in melanoma. Cell. 2019;176(1-2):404. doi:10.1016/j.cell.2018.12.034
1. Tawbi HA, Forsyth PA, Algazi A, et al. Combined nivolumab and ipilimumab in melanoma metastatic to the brain. N Engl J Med. 2018;379:722-730.
1. Long GV, Atkinson V, Lo S, et al. Combination nivolumab and ipilimumab or nivolumab alone in melanoma brain metastases: a multicentre randomised phase 2 study. Lancet Oncol. 2018;19:672-681.
1. Tawbi HAH, Forsyth PAJ, Hodi FS, et al. Efficacy and safety of the combination of nivolumab (NIVO) plus ipilimumab (IPI) in patients with symptomatic melanoma brain metastases (CheckMate 204) [abstract]. J Clin Oncol. 2019;37(15 suppl):9501.
1. Goldberg SB, Gettinger SN, Mahajan A, et al. Pembrolizumab for patients with melanoma or non-small-cell lung cancer and untreated brain metastases: early analysis of a non-randomised, open-label, phase 2 trial. Lancet Oncol. 2016;17:976-983.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Wiley
Medical
- MedlinePlus Health Information